Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
HOLX

HOLX - Hologic Inc Stock Price, Fair Value and News

$75.10-0.10 (-0.13%)
Market Closed

41/100

HOLX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

41/100

HOLX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$63.04

Target 3M

$71.82

Target 6M

$68.82

HOLX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

HOLX Price Action

Last 7 days

0.0%

Last 30 days

0.8%

Last 90 days

1.6%

Trailing 12 Months

4.6%

HOLX RSI Chart

HOLX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

HOLX Valuation

Market Cap

16.7B

Price/Earnings (Trailing)

29.57

Price/Sales (Trailing)

4.08

EV/EBITDA

21.86

Price/Free Cashflow

16.76

HOLX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$63.04

Target 3M

$71.82

Target 6M

$68.82

HOLX Fundamentals

HOLX Revenue

Revenue (TTM)

4.1B

Rev. Growth (Yr)

6.23%

Rev. Growth (Qtr)

2.52%

HOLX Earnings

Earnings (TTM)

565.7M

Earnings Growth (Yr)

4.82%

Earnings Growth (Qtr)

-3.95%

HOLX Profitability

EBT Margin

16.61%

Return on Equity

11.21%

Return on Assets

6.28%

Free Cashflow Yield

5.97%

HOLX Investor Care

Buy Backs (1Y)

5.44%

Diluted EPS (TTM)

2.49

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20254.0B4.0B4.1B0
20244.0B4.0B4.0B4.0B
20234.1B4.0B4.0B4.0B
20225.4B5.2B4.9B4.5B
20215.3B5.7B5.6B5.5B
20203.3B3.3B3.8B4.5B
20193.3B3.3B3.4B3.4B
20183.2B3.2B3.2B3.3B
20172.9B3.0B3.1B3.1B
20162.8B2.8B2.8B0
20152.6B2.7B2.7B2.7B
20142.5B2.5B2.5B2.6B
20132.3B2.5B2.5B2.5B
20121.9B1.9B2.0B2.2B
20111.7B1.8B1.8B1.8B
2010001.7B1.7B
Get all data in R, Python etc through our Historical Stock Data APIs

About Hologic Inc

HOLX
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalovirus; Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment, such as 2D and 3D digital mammography systems, image analytics software, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and ultrasound and connectivity solutions, as well as breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology in the uterus; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; and the CoolSeal portfolio that includes bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
 CEO
 WEBSITEhologic.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES6944

Hologic Inc Frequently Asked Questions

HOLX is the stock ticker symbol of Hologic Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Hologic Inc is 16.73 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check HOLX's fair value in chart for subscribers.

The fair value guage provides a quick view whether HOLX is over valued or under valued. Whether Hologic Inc is cheap or expensive depends on the assumptions which impact Hologic Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HOLX.

As of Wed Jan 28 2026, HOLX's PE ratio (Price to Earnings) is 29.57 and Price to Sales (PS) ratio is 4.08. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HOLX PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Hologic Inc has provided 0.083 (multiply by 100 for percentage) rate of return.